Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 164.5 GBX -0.3% Market Closed
Market Cap: £139.7m

Diaceutics PLC
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Diaceutics PLC
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Diaceutics PLC
LSE:DXRX
Other Items
£601k
CAGR 3-Years
N/A
CAGR 5-Years
197%
CAGR 10-Years
N/A
Oxford Biodynamics PLC
LSE:OBD
Other Items
£1.1m
CAGR 3-Years
-21%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Other Items
£102m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Other Items
£5k
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
-16%
Fusion Antibodies PLC
LSE:FAB
Other Items
£3k
CAGR 3-Years
44%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Other Items
-£8.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-43%
No Stocks Found

Diaceutics PLC
Glance View

Diaceutics Plc engages in the provision of data, data analytics and implementation services. The company is headquartered in Belfast, Northern Ireland. The company went IPO on 2019-03-21. The principal activity of the Company is data analytics and implementation services. The firm is engaged in research and development activities in drug development science, testing data and software platform development. The firm's implementation services include test standardization, test quality assessment, laboratory tech support and others. The firm has established a range of products and outsourced advisory services, which help its pharma clients to optimize and deliver their marketing and implementation strategies for companion diagnostics. The firm provides the pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network. DXRX is the diagnostic commercialization platform for precision medicine, integrating multiple pipelines of diagnostic testing data from a global network of laboratories.

DXRX Intrinsic Value
160.35 GBX
Overvaluation 3%
Intrinsic Value
Price GBX164.5

See Also

What is Diaceutics PLC's Other Items?
Other Items
601k GBP

Based on the financial report for Dec 31, 2024, Diaceutics PLC's Other Items amounts to 601k GBP.

What is Diaceutics PLC's Other Items growth rate?
Other Items CAGR 5Y
197%

Over the last year, the Other Items growth was -7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett